SPK Study in Afghanistan

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Uncomplicated P. Falciparum Malaria
Interventions
DRUG

Artesunate + Sulphadoxine-pyrimethamine

"AS+SP will be administered according to the patient's age, based on a dose of 4mg artesunate/kg body weight once daily for 3 days plus SP at a dose of 25mg sulphadoxine/kg body weight single dose on the first day.~One co-blister pack of Artecospe will be used per patient and obtained via WHO from Guilin Pharmaceutical Co. Ltd., Shanghai China, with appropriate expiry date."

Trial Locations (1)

Unknown

Narang, Asadabad, Watapoor district health centres, Khāş Kunaṟ

All Listed Sponsors
collaborator

World Health Organization

OTHER

lead

University of Oxford

OTHER

NCT01707199 - SPK Study in Afghanistan | Biotech Hunter | Biotech Hunter